The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a ...

About half of the people with prescribed CPAP machines don't use them as prescribed or stop using them altogether because the mask is uncomfortable ... also bundles for ResMed AirSense 10 ($ ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

ResMed makes continuous positive airway pressure machines (CPAP), which offer a non-invasive ... driven by increased demand for its sleep devices and the masks portfolio. Analysts on average ...

Its core business includes the development of devices for sleep apnea -- such as CPAP and APAP machines -- and digital health solutions. Key success factors for ResMed include maintaining ...

Notably, both worldwide devices and masks & other categories experienced robust double-digit growth. Needham maintained a Hold rating for ResMed, citing potential challenges posed by the recent ...